Style | Citing Format |
---|---|
MLA | Panahi Y, et al.. "Sulfur Mustard-Related Ocular Complications: A Review of Proteomic Alterations and Pathways Involved." Current Pharmaceutical Design, vol. 24, no. 24, 2018, pp. 2849-2854. |
APA | Panahi Y, Shahbazi A, Naderi M, Jadidi K, Sahebkar A (2018). Sulfur Mustard-Related Ocular Complications: A Review of Proteomic Alterations and Pathways Involved. Current Pharmaceutical Design, 24(24), 2849-2854. |
Chicago | Panahi Y, Shahbazi A, Naderi M, Jadidi K, Sahebkar A. "Sulfur Mustard-Related Ocular Complications: A Review of Proteomic Alterations and Pathways Involved." Current Pharmaceutical Design 24, no. 24 (2018): 2849-2854. |
Harvard | Panahi Y et al. (2018) 'Sulfur Mustard-Related Ocular Complications: A Review of Proteomic Alterations and Pathways Involved', Current Pharmaceutical Design, 24(24), pp. 2849-2854. |
Vancouver | Panahi Y, Shahbazi A, Naderi M, Jadidi K, Sahebkar A. Sulfur Mustard-Related Ocular Complications: A Review of Proteomic Alterations and Pathways Involved. Current Pharmaceutical Design. 2018;24(24):2849-2854. |
BibTex | @article{ author = {Panahi Y and Shahbazi A and Naderi M and Jadidi K and Sahebkar A}, title = {Sulfur Mustard-Related Ocular Complications: A Review of Proteomic Alterations and Pathways Involved}, journal = {Current Pharmaceutical Design}, volume = {24}, number = {24}, pages = {2849-2854}, year = {2018} } |
RIS | TY - JOUR AU - Panahi Y AU - Shahbazi A AU - Naderi M AU - Jadidi K AU - Sahebkar A TI - Sulfur Mustard-Related Ocular Complications: A Review of Proteomic Alterations and Pathways Involved JO - Current Pharmaceutical Design VL - 24 IS - 24 SP - 2849 EP - 2854 PY - 2018 ER - |